SCHEMBL16616549

SCHEMBL16616549

COc1ccc(C(=O)C=Cc2cccnc2Nc2ccc(F)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.56
ABCG2 Q9UNQ0 2/20 0.53
MCL1 Q07820 1/20 0.53
RAB9A P51151 4/20 0.52
ALDH1A1 P00352 3/20 0.52
NPSR1 Q6W5P4 2/20 0.52
NPC1 O15118 2/20 0.52
HTT P42858 1/20 0.52
CYP3A4 P08684 2/20 0.51
MAPT P10636 7/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
LMNA P02545 1/20 0.50
GAA P10253 1/20 0.50
MAOA P21397 2/20 0.48
CYP1A1 P04798 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP1B1 Q16678 1/20 0.48
MAPK1 P28482 1/20 0.47
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16616546 1.00 MAOB (0.56) MAOBABCG2MCL1RAB9AALDH1A1
SCHEMBL16616864 0.94 ALDH1A1 (0.57) MAOBABCG2MCL1RAB9AALDH1A1
SCHEMBL16616863 0.94 ALDH1A1 (0.57) MAOBABCG2MCL1RAB9AALDH1A1
SCHEMBL16616418 0.91 RAB9A (0.60) MAOBABCG2RAB9AALDH1A1NPSR1
SCHEMBL16616556 0.91 RAB9A (0.60) MAOBABCG2RAB9AALDH1A1NPSR1
SCHEMBL16616552 0.91 RAB9A (0.60) MAOBABCG2RAB9AALDH1A1NPSR1
SCHEMBL16616415 0.91 RAB9A (0.60) MAOBABCG2RAB9AALDH1A1NPSR1
SCHEMBL16616667 0.90 MAPT (0.54) MAOBABCG2MCL1RAB9AALDH1A1
SCHEMBL16616665 0.90 MAPT (0.54) MAOBABCG2MCL1RAB9AALDH1A1
SCHEMBL16616527 0.90 ALDH1A1 (0.53) MAOBABCG2MCL1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006451-B1 2-anilinonicotinyl based chalcones useful as potential anticancer agents and process for preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-14 US disclosed
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof HCCS, WEE2, WEE1 MAOB 2125/4885ABCG2 289/4885MCL1 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.